文献速递神经介入DSACT

双腔球囊辅助Onyx栓塞脑膜中动脉治疗慢性硬膜下血肿

Dual-Lumen Balloon Assisted Onyx Embolization of Middle Meningeal Artery for Chronic Subdural Hematoma.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-10-13

单中心回顾性研究纳入152例慢性硬膜下血肿患者,采用Scepter XC双腔球囊辅助Onyx-18行脑膜中动脉栓塞。3个月随访血肿厚度减少>50%者占90.4%,完全吸收占70.6%,无与双腔球囊技术明确相关的严重不良事件,无复发或再治疗。

要点

  • 双腔球囊辅助Onyx栓塞脑膜中动脉技术上可行,血肿吸收率高。
  • 术后并发症发生率2.6%,均为暂时性,无严重不良事件。
  • 随访期间无血肿复发或再治疗,中位住院2天,手术时间31.5分钟。
英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Middle meningeal artery embolization (MMAE) with liquid embolic agents (LEAs) is increasingly used to manage chronic subdural hematoma (CSDH). Conventional microcatheters require distal wedge positioning of the microcatheter tip or proximal plug formation to prevent reflux and achieve effective distal penetration. Dual-lumen balloon microcatheters limit reflux and enable controlled LEA injection, which may improve procedural efficiency. The evidence base for dual-lumen balloons in CSDH is limited.

MATERIALS AND METHODS: This single-center retrospective study included consecutive adults with CSDH treated from December 2021 to September 2025. The Scepter XC dual-lumen balloon microcatheter was used to arrest antegrade flow and control Onyx-18 delivery, first distal to the anterior branch origin and then from the MMA trunk into the posterior branch. Outcomes included >50% hematoma thickness reduction and complete resolution on computed tomography (CT), recurrence, retreatment, complications, hospital stay, and procedure time.

RESULTS: 152 patients were identified; 33 (21.7%) underwent concomitant surgery and 108 (71.1%) standalone MMAE. Median follow-up was 3 months. This technique achieved >50% hematoma thickness reduction in 90.4% and complete resolution in 70.6% at 3 months or last follow-up. There were no serious adverse events definitely associated with the dual-lumen balloon technique. Overall postprocedural complications occurred in 4 patients (2.6%): transient facial palsy in 2 (1.3%), transient diplopia in 1 (0.7%), and bilateral watershed territory cerebral infarctions without long-term neurological deficits in 1 (0.7%). Median hospital stay was 2 days (IQR 1-4), and median procedure duration was 31.5 minutes (IQR 24.3-48.8). None of the patients who completed follow-up experienced CSDH recurrence or required retreatment.

CONCLUSIONS: Scepter XC-assisted Onyx-18 MMAE was technically feasible and associated with high rates of CSDH resorption and resolution, with a safety profile similar to other MMAE techniques and no serious adverse events directly attributable to dual-lumen balloon microcatheter use.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Madjidov A, Naragum V, Oh D, et al. Dual-Lumen Balloon Assisted Onyx Embolization of Middle Meningeal Artery for Chronic Subdural Hematoma. AJNR Am J Neuroradiol. 2026. PMID: 42869581. doi:10.3174/ajnr.A9678

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。